
Cue Biopharma, Inc. — Investor Relations & Filings
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of injectable, engineered biologics to selectively modulate the human immune system. The company's proprietary platform creates therapeutics designed to mimic natural immune signals to precisely engage, expand, and activate specific, disease-relevant T cells. This targeted approach is being applied to develop immunotherapies for the treatment of cancer and autoimmune diseases, with the goal of restoring immune balance and providing effective treatments for serious conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-02 | English | |
| DEF 14A | 2026-05-21 | English | |
| 8-K | 2026-05-14 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-22 | English | |
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-13 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47939307 | 8-K | 2026-06-02 | English | ||
| 46735308 | DEF 14A | 2026-05-21 | English | ||
| 46257334 | 8-K | 2026-05-14 | English | ||
| 46274638 | 10-Q | 2026-05-14 | English | ||
| 35251607 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-22 | English | ||
| 34434499 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-13 | English | ||
| 33706784 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-07 | English | ||
| 32965297 | S-3 - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-03-17 | English | ||
| 32895721 | 8-K - CUE BIOPHARMA, INC. (0001645460) (Filer) | 2026-02-18 | English | ||
| 31086230 | 8-K Filing | 2026-02-12 | English | ||
| 12882965 | 4 | 2026-01-06 | English | ||
| 12882966 | 4 | 2026-01-06 | English | ||
| 12882967 | 4 | 2026-01-06 | English | ||
| 12882968 | 4 | 2026-01-06 | English | ||
| 12882969 | 4 | 2026-01-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOMARIN PHARMACEUTICAL INC
A global biotechnology company developing therapies for rar…
|
BMRN | US | Manufacturing |
|
BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for cl…
|
BMX | PL | Manufacturing |
|
Biomea Fusion, Inc.
A clinical-stage biopharma developing oral drugs for diabet…
|
BMEA | US | Manufacturing |
|
BIOME AUSTRALIA LIMITED
Develops and distributes evidence-based probiotics and comp…
|
BIO | AU | Manufacturing |
|
Biome Grow Inc.
Production and distribution of cannabis products focused on…
|
BIO | CA | Manufacturing |
|
BIOMERICA INC
Develops in-vitro diagnostic and therapeutic products for c…
|
BMRA | US | Manufacturing |
|
bioMérieux
A global leader in in vitro diagnostics for clinical and in…
|
BIM | FR | Manufacturing |
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
Cue Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34525/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34525 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34525 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34525 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34525}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cue Biopharma, Inc. (id: 34525)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.